Publications launched at IAS 2017
The IAS 2017 conference is used as a focus for many reports and special publications.
New publications will be added to the list below as they become available.
WHO HIV drug resistance report
This new 70-page WHO report was produced with the Global Fund and the US CDS.
The report compiles current levels of HIV drug resistance in different key countries, with implications for choosing first-line ART.
In 6 of the 11 countries surveyed in Africa, Asia and Latin America, over 10% of people have drug resistance to at least one of the main HIV drug classes before starting treatment.
Transition to new antiretroviral drugs in HIV programmes: clinical and programmatic considerations (WHO)
WHO has recommended adopting drug regimens with high potency, lower toxicity, high genetic barriers to resistance, usefulness across different populations and lower cost. The use of optimised drug regimens can improve the durability of the treatment and quality of care of people living with HIV.
Adopting optimised antiretroviral (ARV) drug regimens can significantly affect the speed at which the 90-90-90 targets are achieved, enhancing access to treatment and improving treatment outcomes with impact on treatment adherence, viral suppression and the quality of life of people living with HIV, reducing pressures on health systems and the risk of HIV transmission.
Read and download report from WHO website.
Annual review of the HIV research pipeline, this year available in full and summary versions.
This year this report is part of the i-Base Fit for Purpose report on treatment Ooptimisation (see below).
Fit for Purpose (i-Base)
The July 2017 Fit for Purpose: antiretroviral treatment optimisation for adults and children report provides a comprehensive overview of strategies for treating HIV globally. This includes timelines for new generic drugs and alternative dosing.
It includes chapters on adult and paediatric pipeline reviews.
Read Fit for Purpose online or download PDF versions (launched 10 am 24 July)
IAS/Lancet: Commission on the future of the HIV response and global health
This report on global responses to HIV is based on a programme launched at the previous IAS conference in Vancouver two years ago.